of the Max - MDC
of the Max - MDC
of the Max - MDC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Structure <strong>of</strong> <strong>the</strong> Group<br />
Group Leader<br />
Dr. Daniel Besser<br />
Technical Assistant<br />
Françoise André<br />
Graduate Students<br />
Sebastian Diecke<br />
Angel Quiroga-Negreira<br />
Torben Redmer<br />
A<br />
B<br />
Regulation <strong>of</strong> Pou5F1 and pluripotency genes during early differentiation <strong>of</strong> hESCs; (A) Immunostaining for Pou5F1 (upper panel), combined with nuclear counterstain<br />
(middle panel) and light microscopy (lower panel) <strong>of</strong> undifferentiated (undiff.) H9 hESCs or cells differentiated for 1 (1d diff.) or 3 days (3d diff.). Cell<br />
morphology changes significantly after 3 days <strong>of</strong> differentiation with Pou5F1 protein still detectable. (B) Real-time RT-PCR analysis for <strong>the</strong> expression <strong>of</strong> marker<br />
genes for <strong>the</strong> undifferentiated state, i.e. pou5f1 and nanog, TGFβ signaling, i.e. nodal and lefty-A, and BMP signaling, i.e. msx2 in H9 cells cultured under undifferentiated<br />
conditions (undiff.) and differentiated for different days (1, 3, 5, or 8 days). While <strong>the</strong> pluripotency genes pou5f1 and nanog drop significantly only<br />
after 5 days <strong>of</strong> differentiation, nodal and lefty-A levels decrease and msx2 levels increase much earlier, reflecting molecular changes in <strong>the</strong> cells in <strong>the</strong> initial<br />
phase <strong>of</strong> differentiation.<br />
Mesodermal and cardiomyogenic differentiation<br />
in human embryonic and mesenchymal stem cells<br />
(hMSCs)<br />
Torben Redmer, (START-MSC Consortium, BMBF joint<br />
project grant)<br />
A fraction <strong>of</strong> non-specialized adult stem cells are human<br />
mesenchymal stem cells (hMSCs). They reside in <strong>the</strong> bone<br />
marrow and adipose tissue but are also present in <strong>the</strong> cord<br />
blood and may have <strong>the</strong> potential to become specialized<br />
stem cells, e.g. cardiac progenitor cells. Because it has<br />
already been shown in mice that <strong>the</strong> VEGF receptor 2<br />
(VEGFR2) is involved in differentiation <strong>of</strong> cardiac progenitor<br />
cells, we analyzed hMSCs from all three sources by flowcytometry<br />
and real-time RT-PCR for VEGFR2 expression.<br />
Using flow cytometry we observed an expression <strong>of</strong> <strong>the</strong><br />
receptor <strong>of</strong> nearly 20 % <strong>of</strong> hMSCs. To study <strong>the</strong> regulation<br />
<strong>of</strong> VEGFR2 during early steps <strong>of</strong> cardiomyogenesis we are<br />
using <strong>the</strong> formation <strong>of</strong> embryoid bodies derived from embryonic<br />
stem cell as a model system. Since it is known so far<br />
that <strong>the</strong> transcription factor MesP1 is crucial for <strong>the</strong> differentiation<br />
<strong>of</strong> cardiac progenitor cells coming from <strong>the</strong> primitive<br />
streak, we are also studying its regulation during<br />
embryoid body formation. We are currently analyzing factors<br />
inducing <strong>the</strong> expression <strong>of</strong> MesP1 and VEGFR2 in hMSCs<br />
and are in <strong>the</strong> process to determine <strong>the</strong> effects <strong>of</strong> overexpression<br />
<strong>of</strong> both proteins.<br />
Selected Publications<br />
James, D, Levine, AJ, Besser, D, and Hemmati-Brivanlou, A.<br />
(2005). TGFβ/activin/nodal signaling is necessary for <strong>the</strong><br />
maintenance <strong>of</strong> pluripotency in human embryonic stem cells.<br />
Development 132, 1273-1282.<br />
Diecke, S, Quiroga-Negreira, A, Redmer, T, and Besser, D.<br />
(2007). FGF2 signaling in mouse embryonic fibroblasts is crucial<br />
for self-renewal <strong>of</strong> embryonic stem cells. Cells, Tissues Organs, in<br />
press<br />
84 Cancer Research